Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.31), $0.09 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $150.4 million versus the consensus estimate of $135.83 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.